The research
What the 2024 Stanford study actually found
In January 2024, a Stanford-led team published a study in Nature Medicine following 30 Special Operations Forces veterans with predominantly mild traumatic brain injury and repeated blast exposure. Each received magnesium-ibogaine therapy, and the researchers measured them before and after.
The reported results were striking: significant improvements in PTSD, depression, anxiety, and day-to-day functioning at one month, along with gains in processing speed. Just as importantly, pairing ibogaine with magnesium to protect the heart meant no serious cardiac events were reported.
We want to be precise about what this is and is not. It was an observational study, not a randomized controlled trial, so it shows a strong signal rather than final proof, and individual results vary. We present it as exactly that, real, published, and encouraging, without turning a promising study into a promise.
The mechanism
Why neuroplasticity matters after a brain injury
Recovery from a brain injury is, in large part, a story about neuroplasticity, the nervous system's ability to form new connections and reroute around damage. Traumatic and blast injuries also leave behind chronic neuroinflammation and disrupted neural networks that can keep symptoms locked in place.
Ibogaine acts on these same systems. It promotes neuroplasticity, upregulates neurotrophic signaling (GDNF and BDNF) important to neuronal repair, and reduces pro-inflammatory activity. This is the biological rationale behind the research findings, and it is why the approach is framed around recovery and adaptation rather than any single symptom.
For veterans and first responders, brain injury and trauma often travel together. A mechanism that supports both neural repair and emotional processing is part of why this population has been at the center of the research.
The approach
How the program supports brain-injury recovery
Neuroplasticity Promotion
Support for the nervous system's capacity to form new connections and adapt around injured pathways, the core of brain-injury recovery.
Neurotrophic Support (GDNF/BDNF)
Upregulation of neurotrophic signaling central to neuronal repair and survival after injury.
Neuroinflammation Modulation
Reduction of the chronic inflammatory activity that can follow traumatic and blast injury and sustain symptoms.
Magnesium Cardiac-Safety Protocol
The same heart-protective approach used in the published research, with rigorous cardiac screening and continuous monitoring throughout.
Trauma & Mood, Together
Because TBI and PTSD so often overlap in veterans, the program addresses emotional processing alongside neural recovery.
Measured, Not Assumed
Cognitive, mood, and functional baselines are captured and re-measured, so progress is tracked honestly rather than hoped for.
The process
A careful, safety-gated program
Candidacy & cardiac screening
Our medical team reviews injury history, cardiac health (ECG and electrolytes), medications, and overall fitness. Cardiac safety is non-negotiable and comes first.
Neuroplastic priming
An anti-inflammatory and neurotrophic preparation phase under medical supervision, with the magnesium cardiac-protection protocol.
Supervised session
The medically supervised session under continuous cardiac monitoring, mirroring the safety approach used in the research.
Integration & honest measurement
Structured integration focused on cognition, mood, and function, with re-measurement against baseline and realistic follow-up.
Primary References
Our protocols align with the primary scientific literature, including the MAPS Ibogaine Investigator's Brochure (July 2026), NIDA's psychedelic & dissociative drugs research, and registered trials on ClinicalTrials.gov. Ibogaine remains investigational; we pair published evidence with measured, real-world outcome tracking.
Measured & safe
Recovery you can track. Safety you can trust.
Our proprietary data system measures your progress before, during, and after your stay, and monitors your safety at every step. The same data that keeps you safe is the data that proves it worked.
Validated instruments build your baseline before you travel.
Cardiac and vital monitoring around your session, read in real time.
Your progress re-scored against your baseline, in your portal.
Every MindScape treatment program includes a guided 5-MeO-DMT (Bufo) ceremony — part of the all-inclusive price, not an add-on.
Questions
Ibogaine for TBI, answered honestly
Precision dosing
Your main dose is measured, not estimated
Before the main session, we give a short series of low, sub-psychoactive ibogaine TA boosters. Each one is a measurement. Ibogaine and its long-lived metabolite noribogaine both affect the heart's hERG potassium channel, and that effect is dose-dependent, so instead of predicting how you will respond we observe it directly at doses far below a full session. Your main dose is then chosen from your own cardiac response and the margin you have left.
No ibogaine given. 12-lead ECG, electrolytes and liver panel establish the starting point. A baseline outside safe limits stops the programme here.
These are the measurements the protocol is built around. The trace above is a schematic used to explain the method; it is not a recording of a patient, and the values shown are illustrative rather than results.
How the booster protocol works for traumatic brain injury →Related programs: Veterans & PTSD · PTSD, C-PTSD & TBI program · First responders · Neurological overview
Looking for ibogaine treatment for traumatic brain injury accessible from your state? MindScape Retreat treats patients from across the US with direct flights to Cozumel. Find ibogaine treatment near you.